Regression of murine lung tumors by the let-7 microRNA

被引:376
作者
Trang, P. [2 ,3 ]
Medina, P. P. [2 ]
Wiggins, J. F. [1 ]
Ruffino, L. [1 ]
Kelnar, K. [1 ]
Omotola, M. [1 ]
Homer, R. [4 ,5 ]
Brown, D. [1 ]
Bader, A. G. [1 ]
Weidhaas, J. B. [3 ]
Slack, F. J. [2 ]
机构
[1] Mirna Therapeut Inc, Austin, TX USA
[2] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[5] VA Connecticut Healthcare Syst, Dept Pathol & Lab Med Serv, West Haven, CT USA
关键词
let-7; microRNAs; lung cancer; K-ras; MOUSE MODELS; K-RAS; CANCER; EXPRESSION; INHIBITION; FAMILY; GROWTH; CELLS; SIRNA; HMGA2;
D O I
10.1038/onc.2009.445
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) have recently emerged as an important new class of cellular regulators that control various cellular processes and are implicated in human diseases, including cancer. Here, we show that loss of let-7 function enhances lung tumor formation in vivo, strongly supporting the hypothesis that let-7 is a tumor suppressor. Moreover, we report that exogenous delivery of let-7 to established tumors in mouse models of non-small-cell lung cancer (NSCLC) significantly reduces the tumor burden. These results demonstrate the therapeutic potential of let-7 in NSCLC and point to miRNA replacement therapy as a promising approach in cancer treatment. Oncogene (2010) 29, 1580-1587; doi:10.1038/onc.2009.445; published online 7 December 2009
引用
收藏
页码:1580 / 1587
页数:8
相关论文
共 32 条
[1]   Inhibition of respiratory viruses by nasally administered siRNA [J].
Bitko, V ;
Musiyenko, A ;
Shulyayeva, O ;
Barik, S .
NATURE MEDICINE, 2005, 11 (01) :50-55
[2]  
Bitko Vira, 2008, V442, P75, DOI 10.1007/978-1-59745-191-8_6
[3]   Apoptosis genes and resistance to cancer therapy - What do the experimental and clinical data tell us? [J].
Brown, M ;
Wilson, G .
CANCER BIOLOGY & THERAPY, 2003, 2 (05) :477-490
[4]   Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [J].
Calin, GA ;
Sevignani, C ;
Dan Dumitru, C ;
Hyslop, T ;
Noch, E ;
Yendamuri, S ;
Shimizu, M ;
Rattan, S ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :2999-3004
[5]   MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias [J].
Calin, GA ;
Liu, CG ;
Sevignani, C ;
Ferracin, M ;
Felli, N ;
Dumitru, CD ;
Shimizu, M ;
Cimmino, A ;
Zupo, S ;
Dono, M ;
Dell'Aquila, ML ;
Alder, H ;
Rassenti, L ;
Kipps, TJ ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11755-11760
[6]   Death by design: apoptosis, necrosis and autophagy [J].
Edinger, AL ;
Thompson, CB .
CURRENT OPINION IN CELL BIOLOGY, 2004, 16 (06) :663-669
[7]   Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[8]   Post-embryonic expression of C-elegans microRNAs belonging to the lin-4 and let-7 families in the hypodermis and the reproductive system [J].
Esquela-Kerscher, A ;
Johnson, SM ;
Bai, L ;
Saito, K ;
Partridge, J ;
Reinert, KL ;
Slack, FJ .
DEVELOPMENTAL DYNAMICS, 2005, 234 (04) :868-877
[9]   The let-7 microRNA reduces tumor growth in mouse models of lung cancer [J].
Esquela-Kerscher, Aurora ;
Trang, Phong ;
Wiggins, Jason F. ;
Patrawala, Lubna ;
Cheng, Angie ;
Ford, Lance ;
Weidhaas, Joanne B. ;
Brown, David ;
Bader, Andreas G. ;
Slack, Frank J. .
CELL CYCLE, 2008, 7 (06) :759-764
[10]   Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt [J].
Hohla, Florian ;
Schally, Andrew V. ;
Kanashiro, Celia A. ;
Buchholz, Stefan ;
Baker, Benjamin ;
Kannadka, Chandrika ;
Moder, Angelika ;
Aigner, Elmar ;
Datz, Christian ;
Halmos, Gabor .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (47) :18671-18676